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The U.S. Environmental Protection Agency
(EPA) released its Dioxin Reassessment in
draft form in 2000, which concluded that
dioxin should be classiﬁed as a known human
carcinogen (U.S. EPA 2000). It also con-
cluded that the upper limit of human cancer
risk for the general population is about 1 in
1,000, based on current background body
burdens in the United States of approximately
5 ng toxic equivalents (TEQ) per kilogram
body weight. This risk assessment was based
on the standard low-dose linear extrapolation
method (U.S. EPA 2000).
During the U.S. EPA Science Advisory
Board’s (SAB) review of the dioxin reassess-
ment, there was a great deal of discussion of
the methods used by the U.S. EPA to calcu-
late low-dose cancer risk, and it was suggested
that other approaches to estimating this risk
should be considered (U.S. EPA 2001).
During the SAB review, only one alternative
calculation of dioxin’s cancer risk was pre-
sented, and it was discussed at some length.
That analysis suggested that dioxin is a
threshold carcinogen and that the threshold is
an order of magnitude higher than the expo-
sure levels of the general population (Aylward
LL. Unpublished data). This contrasts with
the conclusions of Steenland et al. (2001) and
Becher et al. (1998), who, using more stan-
dard statistical approaches, found no evidence
of a threshold. Because the threshold model
received considerable attention during the
U.S. EPA SAB review, we have undertaken a
review of the methods and findings of the
threshold analysis.
Linear Model as a Threshold
Indicator
This threshold analysis was based on a num-
ber of related publications (Hays et al. 2001;
Kirman et al. 2000a, 2000b) that examined
the possibility of a dioxin threshold using a
log-linear regression model. This model can
be expressed as
SMR = A + B logE, [1]
where SMR is the standard mortality ratio, E
is exposure, and A and B are regression para-
meters. This model can be interpreted as
indicating a threshold if the E intercept of the
best-ﬁt line is greater than zero with an SMR
of 100 (Figure 1). One sees this more clearly
by rewriting the Equation 1 as
SMR = 100 + B (logE – logT ). [2]
The variable T is the threshold level at which
any higher level of exposure will give an SMR
of > 100. Of course, because Equation 1 is a
simple linear model, the SMR would be < 100
at exposure levels below the threshold. This
line should not be interpreted as a physical
dose–response function; its purpose is to serve
as an indicator of threshold behavior. If the
simple linear model indicated the presence of a
threshold, a more detailed analysis with a more
complex model would be needed to explore
the shape of the dose–response function.
Different analyses of the cancer risk from
dioxin have been based on different epidemio-
logic studies, using different dose metrics and
different interpretations of the exposures. The
U.S. EPA based its analysis of the dioxin can-
cer risk for humans (U.S. EPA 2000) on three
studies, referred to as Hamburg (Flesch-Janys
et al. 1998), BASF (Ott and Zober 1996), and
NIOSH (National Institute of Occupational
Safety and Health) (Aylward et al. 1996). The
U.S. EPA excluded the Seveso study of a pop-
ulation exposed to dioxin from an industrial
accident (Bertazzi et al. 1998) and the Ranch
Hand study of exposed Vietnam Veterans
(Roegner et al. 1991), arguing that these
studies were not sufﬁciently reliable. In con-
trast, the dioxin threshold analyses of
Aylward (Unpublished data), Kirman et al.
(2000a), and Hays et al. (2001) include the
Ranch Hand and Seveso studies. The analyses
by Kirman et al. (2000a) and Hays et al.
(2001) included Seveso, NIOSH, and Ranch
Hand but excluded BASF and Hamburg.
The analysis by Aylward (Unpublished data)
presented to the U.S. EPA SAB included all
ﬁve studies.
In this article we discuss one example of
these threshold analyses, following that of Hays
et al. (2001)—with exposure data expressed as
lifetime average serum lipid 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) concentra-
tion—and using the standard mortality data
for all cancers combined (Table 1). Analyses
for other measures of exposure and other data
sets yield results that are quantitatively differ-
ent but qualitatively similar to this example.
In following Hays et al., we are not making
judgments about these data or the appropri-
ateness of combining the data into a single
analysis. Our approach is to use the same data
and the same model as the studies that have
concluded that dioxin is a threshold carcino-
gen, in order to explore the basis of those
conclusions.
Log-Linear Regression Results
A key feature of the published threshold analy-
ses is that each point has been weighted by the
size of the cohort. This has a signiﬁcant effect
on the results because, as shown in Table 1,
two of the data points from the Seveso study
represent 15,000 people, whereas one of the
Ranch Hand data points represents only 19
people. In the population-weighted analysis,
the Seveso zone R female data point was
weighted by a factor of 15,000, as was the
Seveso zone R male data point, whereas the
Ranch Hand nonﬂying ofﬁcer data point was
weighted by a factor of only 19. Thus, the
effect of the population weighting is to drive
the best-fit line through the two data points
from Seveso zone R.
There is no justiﬁcation for weighting the
data by cohort size. The statistical power of
the larger cohort size is already reflected in
the size of the confidence interval for each
point.
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Research CommentaryFigure 1 shows the best-ﬁt point analysis
of the data in Table 1. The best-fit “thresh-
old” is about 0.5 ng/kg for the unweighted
(correct) regression. This is well below the
range of background exposures of the gen-
eral population, which has been reported to
be about 3–5 ng/kg (Kirman et al. 2000a).
In contrast, the weighted (incorrect) regres-
sion indicates a threshold of about 60 ng/kg,
consistent with the results reported by
Aylward (Unpublished data), Kirman et al.
(2000a), and Hays et al. (2001). Note that
the weighted regression line passes very close
to the two low-dose Seveso data points as a
result of the heavy weighting of those two
points.
This point analysis does not provide
meaningful measures of the uncertainty in
the ﬁt because the SMR uncertainties are not
included in the analysis. However, the scatter
and uncertainties in the SMR values are very
large, as shown in Figure 1. Consequently,
the uncertainty in the best-ﬁt threshold value
can be expected to be high. An error-
weighted chi-square fit can indicate the
uncertainties. The best-fit line can be calcu-
lated by minimizing the error-weighted chi-
square function
[3]
where A and B are as defined in Equation 1
and σi is the uncertainty in the ith SMR
value (Press et al. 1987). Because this least-
squares ﬁt takes into account the uncertainty
associated with each SMR value, it produces
a somewhat different best-fit line than does
the result from a least-squares ﬁt that ignores
the uncertainties in SMR. Also, as the values
of σi increase, χ2 decreases. For the
unweighted regression (i.e., the regression
that is not weighted by population), the
value of χ2 defined by Equation 3 is 6.3.
This is well below the value from χ2 tables
for 12 degrees of freedom and 95% confi-
dence, which is 21, indicating that the log-
linear model of Equation 1 is statistically
consistent with the data set. However, the
uncertainty in the threshold value spans sev-
eral orders of magnitude, ranging from zero
to > 100 ng/kg, and therefore could be con-
sistent either with the threshold value calcu-
lated with the population-weighted model,
or with a zero threshold. Therefore, the
emphasis should not be on the fact that the
best-fit threshold value for the unweighted
regression happens to fall below the range of
general population exposures, but rather on
the very large uncertainty in the estimate of
the threshold.
Monte Carlo Analysis
The studies by Aylward (Unpublished data),
Kirman et al. (2000a), and Hays et al. (2001)
use Monte Carlo analysis to calculate the
uncertainty. We have undertaken a similar
analysis for both the unweighted and the
population-weighted models, and these
results are shown in Figure 2. We chose the
SMR distributions so that the confidence
intervals match those specified in Table 1.
We tried several distributions, including
Poisson distributions, and found that the
results are largely independent of the details
of the SMR distributions.
Figure 2 shows that in the population-
weighted model, the threshold distribution is
above the background exposure and is
approximately one order of magnitude wide,
consistent with the results reported by
Aylward (Unpublished data), Kirman et al.
(2000a), and Hays et al. (2001) However, in
the unweighted model, Figure 2 shows that
the distribution is very broad, covering more
than three orders of magnitude, and overlaps
the range of the general population back-
ground exposure. This broad distribution of
potential thresholds is consistent with the
high degree of scatter and uncertainty of the
epidemiologic data.
Conclusions
We agree with Aylward (Unpublished data),
Kirman et al. (2000a), and Hays et al.
(2001) that the log-linear model of Equation
1 is an interesting exploratory approach to
analysis of a threshold effect. However,
although this general approach can be useful,
the reported high threshold is incorrect,
because of the incorrect weighting of the
data.
Without the population weighting, the
range of potential thresholds is very wide, it
completely overlaps the level of general
background exposures, and it is consistent
with a threshold of zero. Therefore, this
analysis provides no evidence for or against
the proposition that dioxin is a threshold
carcinogen.
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Table 1. TCDD exposure and SMR data.
Exposureb,c SMR for total cancersb
Subcohorta Cohort size (ng/kg) (95% CI)
NIOSH
< 1 year exposure 1,516 111 102 (75–133)
1 to < 5 year exposure 507 413 165 (119–198)
5 to < 15 year exposure 507 738 138 (97–186)
≥ 15 year exposure 507 2,218 115 (68–175)
Seveso
Zone R (female) 15,000 16 90 (80 – 100)
Zone B (female) 2,500 62 90 (70–120)
Zone A (female) 375 420 120 (60–220)
Zone R (male) 15,000 23 90 (80–100)
Zone B (male) 2,500 51 110 (90–130)
Zone A (male) 375 485 40 (20–100)
Ranch Hand
Flying ofﬁcer 300 6.4 87 (44–155)
Nonﬂying ofﬁcer 19 5.8 173 (9–850)
Flying enlisted 148 9.9 102 (47–194)
Nonﬂying enlisted 399 13 83 (44–155)
CI, conﬁdence interval.
aNIOSH cohort data from Fingerhut et al. (1991), Seveso cohort data from Kirman et al. (2000a), and Ranch Hand cohort
data from Aylward et al. (1996). bExposure expressed as lifetime average serum lipid TCDD levels. cExposure and SMR
data from Kirman et al. (2000a) and Hays et al. (1997).
Figure 1. Population-weighted and unweighted 
linear-log regressions of SMR for all cancers ver-
sus TCDD exposure (data from Table 1). The shaded
area shows the range of general population TCDD
exposures.
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Figure 2. Distribution of possible dioxin cancer
“thresholds” from Monte Carlo analysis of
unweighted and weighted models. The shaded
area shows the range of general population TCDD
exposures.
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